Skip to main content
. 2021 Apr 15;22(8):4102. doi: 10.3390/ijms22084102

Figure 5.

Figure 5

In vivo anti-tumor effect of Ad-shRRM1 on RRM1 highly expressed RT112 xenografts. RT112 tumors, treated with Ad-shScramble or Ad-shRRM1, were enucleated 31 days after initiation of treatment. Images show (A) the appearance and (B) tumor volumes of RRM1 highly expressed RR112 xenografts in nude mice. (*: p < 0.05 versus Ad-shScramble treatment group).